Circulation, Vol 52, 88-102, Copyright © 1975 by American Heart Association
AG Morrow, BA Reitz, SE Epstein, WL Henry, DM Conkle, SB Itscoitz and DR Redwood
The results of operative treatment in 83 patients with idiopathic
hypertrophic subaortic stenosis (IHSS) are described. Most patients with
the disease are asymptomatic, or derive satisfactory symptomatic
improvement from nonoperative therapy: administration of propranolol,
exerice limitation, control of arrhythmia, etc. Operation is required,
however, in 10-15% of patients, those who remain severely symptomatic after
nonoperative treatment or who become refractory to it. Operation relieves
symptoms in IHSS by relieving obstruction to left ventricular outflow, and
for a patient to be considered an operative candidate severe obstruction
must be documented at left heart catheterization either under resting
conditions or after provocative interventions. All 83 patients were
severely incapacitated--58 in Class III and 24 in Class IV. Seventy had
obstruction at rest (average gradient 96 mm Hg), and 13 had only provocable
obstruction. At operation the hypertrophic interventricular septum was
exposed via an aortotomy, and a vertical bar of muscle was resected between
parallel myotomy incisions. There were six operative deaths (7%); no
patient has died since 1970. Seven patients have died late after operation,
five of them from causes unrelated to their heart disease or the operation.
All surviving patients describe symptomatic improvement. Fifty-two patients
with obstruction at rest preoperatively (average gradient 95 mm Hg) have
been studied postoperatively: no resting gradient was evident in 47, while
in the remaining five the gradient was less than 25 mm Hg. Recurrence of
obstruction has never been observed at late catheterization (21 pts) or
late echocardiographic examination (37 pts). Obstruction could not be
provoked postoperatively in ten of the 11 patients who had large gradients
only with the Valsalva maneuver or isoproterenol administration
preoperatively. Obstructed and provocable obstructed patients had similar
symptomatic improvement after operation. A variety of rhythm and conduction
abnormalities were observed both pre and postoperatively, and these are
described in detail. The results of operation in these 83 patients with
IHSS demonstrate that gratifying symptomatic and hemodynamic improvement
uniformly follows left ventriculomyotomy and myectomy. Relief of
obstruction and amelioration of symptoms have proved to be long-lasting
during postoperative observation periods extending to 14 years. Continued
application of the operative procedure in properly selected patients
appears to be indicated.
ARTICLES
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients
This article has been cited by other articles:
![]() |
A. M. Jacques, N. Briceno, A. E. Messer, C. E. Gallon, S. Jalilzadeh, E. Garcia, G. Kikonda-Kanda, J. Goddard, S. E. Harding, H. Watkins, et al. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy Cardiovasc Res, May 20, 2008; (2008) cvn094v3. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF] |
||||
![]() |
C. J. McLeod, S. R. Ommen, M. J. Ackerman, P. L. Weivoda, W. K. Shen, J. A. Dearani, H. V. Schaff, A. J. Tajik, and B. J. Gersh Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy Eur. Heart J., November 1, 2007; 28(21): 2583 - 2588. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy Circulation, July 10, 2007; 116(2): 196 - 206. [Full Text] [PDF] |
||||
![]() |
M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF] |
||||
![]() |
M. S. Maron, I. Olivotto, A. G. Zenovich, M. S. Link, N. G. Pandian, J. T. Kuvin, S. Nistri, F. Cecchi, J. E. Udelson, and B. J. Maron Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction Circulation, November 21, 2006; 114(21): 2232 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Elliott, J. R. Gimeno, M. T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W. J. McKenna Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy Eur. Heart J., August 2, 2006; 27(16): 1933 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Binder, M. A. Fifer, M. E. King, and J. R. Stone Case 26-2005 - A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging N. Engl. J. Med., August 25, 2005; 353(8): 824 - 832. [Full Text] [PDF] |
||||
![]() |
S. R. Ommen, B. J. Maron, I. Olivotto, M. S. Maron, F. Cecchi, S. Betocchi, B. J. Gersh, M. J. Ackerman, R. B. McCully, J. A. Dearani, et al. Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., August 2, 2005; 46(3): 470 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. van der Lee, F. J. ten Cate, M. L. Geleijnse, M. J. Kofflard, C. Pedone, L. A. van Herwerden, E. Biagini, W. B. Vletter, and P. W. Serruys Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets Circulation, July 26, 2005; 112(4): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura The case for surgery in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2044 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
F H Gietzen, C J Leuner, L Obergassel, C Strunk-Mueller, and H Kuhn Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients Heart, June 1, 2004; 90(6): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF] |
||||
![]() |
C. van der Lee, M. J.M. Kofflard, L. A. van Herwerden, W. B. Vletter, and F. J. ten Cate Sustained Improvement After Combined Anterior Mitral Leaflet Extension and Myectomy in Hypertrophic Obstructive Cardiomyopathy Circulation, October 28, 2003; 108(17): 2088 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Caldarone, T. L. Van Natta, J. R. Frazer, and D. M. Behrendt The modified Konno procedure for complex left ventricular outflow tract obstruction Ann. Thorac. Surg., January 1, 2003; 75(1): 147 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Firoozi, P.M. Elliott, S. Sharma, A. Murday, S.J. Brecker, M.S. Hamid, B. Sachdev, R. Thaman, and W.J. McKenna Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes Eur. Heart J., October 2, 2002; 23(20): 1617 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Gietzen, C. J. Leuner, L. Obergassel, C. Strunk-Mueller, and H. Kuhn Role of Transcoronary Ablation of Septal Hypertrophy in Patients With Hypertrophic Cardiomyopathy, New York Heart Association Functional Class III or IV, and Outflow Obstruction Only Under Provocable Conditions Circulation, July 23, 2002; 106(4): 454 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.A. Schoendube Surgical treatment of hypertrophic obstructive cardiomyopathy Eur. Heart J. Suppl., October 1, 2001; 3(suppl_L): L26 - L31. [Abstract] [PDF] |
||||
![]() |
W. H. Spencer III and R. Roberts Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy : The Need for a Registry Circulation, August 8, 2000; 102(6): 600 - 601. [Full Text] [PDF] |
||||
![]() |
M. Y. Henein, C. A. O'Sullivan, I. S. Ramzy, U. Sigwart, and D. G. Gibson Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1117 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points J. Am. Coll. Cardiol., July 1, 1999; 34(1): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, R. A. Nishimura, W. J. McKenna, H. Rakowski, M. E. Josephson, and R. S. Kieval Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy : A Randomized, Double-Blind, Crossover Study (M-PATHY) Circulation, June 8, 1999; 99(22): 2927 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, S. A. Casey, L. C. Poliac, T. E. Gohman, A. K. Almquist, and D. M. Aeppli Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort JAMA, February 17, 1999; 281(7): 650 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Takagi, T. Yamakado, and T. Nakano Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., January 1, 1999; 33(1): 206 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, R. A. Nishimura, and G. K. Danielson Pitfalls in Clinical Recognition and a Novel Operative Approach for Hypertrophic Cardiomyopathy With Severe Outflow Obstruction Due to Anomalous Papillary Muscle Circulation, December 8, 1998; 98(23): 2505 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Lakkis, S. F. Nagueh, N. S. Kleiman, D. Killip, Z.-X. He, M. S. Verani, R. Roberts, and W. H. Spencer III Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy Circulation, October 27, 1998; 98(17): 1750 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Roughneen, S. Y. DeLeon, F. Cetta, D. A. Vitullo, T. J. Bell, E. A. Fisher, B. P. Blakeman, and M. Bakhos Modified Konno-Rastan Procedure for Subaortic Stenosis: Indications, Operative Techniques, and Results Ann. Thorac. Surg., May 1, 1998; 65(5): 1368 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gol, M. Emir, T. Keles, S. A. Kucuker, C. L. Birincioglu, Y. H. Karagoz, T. Kural, O. Tasdemir, S. Goksel, and K. Bayazit Septal Myectomy in Hypertrophic Obstructive Cardiomyopathy: Late Results With Stress Echocardiography Ann. Thorac. Surg., September 1, 1997; 64(3): 739 - 745. [Abstract] [Full Text] |
||||
![]() |
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF] |
||||
![]() |
Y. Imoto, H. Kado, H. Yasuda, R. Tominaga, and H. Yasui Subaortic Stenosis Caused by Anomalous Papillary Muscle of the Mitral Valve Ann. Thorac. Surg., December 1, 1996; 62(6): 1858 - 1860. [Abstract] [Full Text] |
||||
![]() |
R. B. McCully, R. A. Nishimura, A. J. Tajik, H. V. Schaff, and G. K. Danielson Extent of Clinical Improvement After Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy Circulation, August 1, 1996; 94(3): 467 - 471. [Abstract] [Full Text] |
||||
![]() |
R. C. Robbins and E. B. Stinson LONG-TERM RESULTS OF LEFT VENTRICULAR MYOTOMY AND MYECTOMY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 586 - 594. [Abstract] [Full Text] |
||||
![]() |
F. A. Schoendube, H. G. Klues, S. Reith, F. A. Flachskampf, P. Hanrath, and B. J. Messmer Long-term Clinical and Echocardiographic Follow-up After Surgical Correction of Hypertrophic Obstructive Cardiomyopathy With Extended Myectomy and Reconstruction of the Subvalvular Mitral Apparatus Circulation, November 1, 1995; 92(9): 122 - 127. [Abstract] [Full Text] |
||||
![]() |
G. M. Folger The Spectrum of Left Ventricular Outflow Tract Obstruction: an Overview Angiology, November 1, 1980; 31(11): 779 - 799. [PDF] |
||||
![]() |
J. Bensaid Idiopathic Hypertrophic Subaortic Stenosis and Associated Coronary Artery Disease: Clinical, Hemodynamic, and Therapeutic Features From a Review of 57 Cases of the Literature Angiology, September 1, 1979; 30(9): 585 - 593. [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1975 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |